Literature DB >> 30743057

Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance.

Yazmin Brown1, Susan Hua2, Pradeep S Tanwar3.   

Abstract

The identity of cancer stem cells (CSCs) remains an enigma, with the question outstanding of whether CSCs are fixed entities or plastic cell states in response to microenvironmental cues. Recent evidence highlights the power of the tumor microenvironment to dictate CSC functionality and spatiotemporal regulation that gives rise to tumor heterogeneity. This microenvironmental regulation of CSCs parallels that of normal tissues, whereby resident stem cells reside within specialized microenvironments or 'niches', which provide the cellular and molecular signals that wire every aspect of stem cell behavior and fate. The extracellular matrix (ECM), along with its sequestered growth factors, is a fundamental component of the stem cell niche. Pathological ECM remodeling is an established hallmark of cancer, with the ECM a key mediator of metastasis and drug resistance. In this review, we discuss the controversial identity of CSCs and new understanding of the impact of tumor microenvironment on CSC function and phenotype. We outline parallels between development, wound repair and cancer to discuss how changes in ECM dynamics influence stem cell function during normal physiological processes and pathological states, as well as the transition between the two in the form of precancerous lesions. We then explore examples illustrating the molecular circuits partnering cancer cells with stromal cells and how this communication involving ECM imparts a CSC phenotype and promotes chemoresistance. Understanding the mechanisms underlying CSC functionality and chemoresistance, along with mathematical modeling approaches and advancing technologies for targeting the undruggable proteome, should open opportunities for cancer breakthroughs in the future.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; CSCs; Cancer; Chemoresistance; Drug resistance; ECM; EMT; Epidermolysis bullosa; Extracellular matrix; Glioblastoma; Ovarian cancer; Squamous cell carcinoma; Stem cells; Tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 30743057     DOI: 10.1016/j.biocel.2019.02.002

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  23 in total

Review 1.  Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.

Authors:  Ritama Paul; Jay F Dorsey; Yi Fan
Journal:  Pharmacol Ther       Date:  2021-09-01       Impact factor: 12.310

2.  Integrated RNA Sequencing and Single-Cell Mass Cytometry Reveal a Novel Role of LncRNA HOXA-AS2 in Tumorigenesis and Stemness of Hepatocellular Carcinoma.

Authors:  Qinchen Lu; Jiamin Gao; Shaomei Tang; Zhijian Li; Xi Wang; Caiwang Deng; Jiaxin Hu; Yuting Tao; Qiuyan Wang
Journal:  Onco Targets Ther       Date:  2020-10-27       Impact factor: 4.147

Review 3.  Blood and Cancer: Cancer Stem Cells as Origin of Hematopoietic Cells in Solid Tumor Microenvironments.

Authors:  Ghmkin Hassan; Masaharu Seno
Journal:  Cells       Date:  2020-05-22       Impact factor: 6.600

Review 4.  Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response.

Authors:  Vasudeva Bhat; Alison L Allan; Afshin Raouf
Journal:  Cancers (Basel)       Date:  2019-08-24       Impact factor: 6.639

5.  Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure.

Authors:  Marta Guerra-Rebollo; Cristina Garrido; Lourdes Sánchez-Cid; Carolina Soler-Botija; Oscar Meca-Cortés; Nuria Rubio; Jerónimo Blanco
Journal:  Sci Rep       Date:  2019-07-02       Impact factor: 4.379

Review 6.  Gastric Cancer Stem Cells: Current Insights into the Immune Microenvironment and Therapeutic Targets.

Authors:  Lingfeng Fu; Luke Bu; Tadahito Yasuda; Mayu Koiwa; Takahiko Akiyama; Tomoyuki Uchihara; Hideo Baba; Takatsugu Ishimoto
Journal:  Biomedicines       Date:  2020-01-06

7.  Second-harmonic generation directionality is associated with neoadjuvant chemotherapy response in breast cancer core needle biopsies.

Authors:  Danielle E Desa; Monisha Bhanote; Robert L Hill; Joseph B Majeski; Brandon Buscaglia; Marcus D'Aguiar; Robert Strawderman; David G Hicks; Bradley M Turner; Edward B Brown
Journal:  J Biomed Opt       Date:  2019-08       Impact factor: 3.170

8.  EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer.

Authors:  Xiaojie Liu; Mingjing He; Linlin Li; Xiya Wang; Shuhua Han; Jinzhu Zhao; Yalong Dong; Mushtaq Ahmad; Leilei Li; Xueyan Zhang; Junfeng Huo; Yunfan Liu; Chengxue Pan; Cong Wang
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

9.  A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix.

Authors:  Chunlai Yu; Mingliang You; Peizhen Zhang; Sheng Zhang; Yuzhu Yin; Xiao Zhang
Journal:  Cancer Med       Date:  2021-06-14       Impact factor: 4.452

Review 10.  Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.

Authors:  Jun-Nan Guo; Bai-Rong Xia; Shen-Hui Deng; Chang Yang; Ya-Nan Pi; Bin-Bin Cui; Wei-Lin Jin
Journal:  Front Cell Dev Biol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.